COMMUNIQUÉS West-GlobeNewswire

Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL151 for Parkinson’s Disease and Launch of Its Engage Parkinson’s Website
04/09/2019
Phase 1b study of DNL151 includes Parkinson’s disease patients with and without a genetic LRRK2 mutation Either DNL151 or DNL201 anticipated to be selected for potential registrational clinical trials in 2020 The Engage [...]
Ozop Surgical Corp. Announces Addition of Spine Industry Veteran to Lead its Sales Team
04/09/2019
Ozop adds Nick Ansari as Executive Vice President of Sales and Marketing WEST PALM BEACH, FL, Sept. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Ozop Surgical Corp. (OTCQB: OZSC), a provider of premium surgical [...]
American Society for Gastrointestinal Endoscopy Includes WATS3D in Its New Practice Guideline for the Screening and Surveillance of Barrett’s Esophagus
04/09/2019
SUFFERN, N.Y., Sept. 04, 2019 (GLOBE NEWSWIRE) -- CDx Diagnostics, developer of the WATS 3D diagnostic platform for the screening and surveillance of Barrett’s esophagus (BE), a known precursor to esophageal cancer (EC [...]
BioNovelus, Inc. Announces Chuck Zingler to Join Advisory Board
04/09/2019
POTOMAC, Md., Sept. 04, 2019 (GLOBE NEWSWIRE) -- BioNovelus, Inc. (OTCMARKETS: ONOV) announces Mr. Chuck Zingler will join the Company’s newly created Advisory Board. BioNovelus’ Advisory Board seats individual [...]
Revenue Maximization Group Recognized by CIO Applications Magazine as Top 25 Healthcare Solutions Provider
04/09/2019
Newly Acquired Division of Nexteligent Holdings, Inc. Delivers Revenue Cycle Management and Preventative Wellness Services LAS VEGAS, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Nexteligent Holdings, Inc. f/k/a Efftec [...]
30,000 Canadian Businesses to Benefit from Teladoc Telemedicine Services
04/09/2019
Employees of small- to mid-size companies to have faster access to medical care TORONTO, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, announces today its partnership [...]
Les Services de télémédecine de Teladoc bénéficieront à 30 000 entreprises canadiennes
04/09/2019
Un accès plus rapide à des soins médicaux pour les employés des petites et moyennes entreprises TORONTO, 04 sept. 2019 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE : TDOC), le chef de file mondial de solutions virtuelles de [...]
30,000 Canadian Businesses to Benefit from Teladoc Telemedicine Services
04/09/2019
Employees of small- to mid-size companies to have faster access to medical care TORONTO, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, announces today its partnership [...]
Bellerophon to Present at the H.C. Wainwright 21st Annual Global Investment Conference
04/09/2019
WARREN, N.J., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, announced today that Fabian Tenenbaum, Chief [...]
Noblegen Adds Two Top Industry Executives to its Board of Directors
04/09/2019
Former General Mills EVP of Innovation Technology and Quality, Peter Erickson, and current VP & CFO of JRSL Don Solman join Noblegen’s Board of Directors PETERBOROUGH, Ontario, Sept. 04, 2019 (GLOBE NEWSWIRE) -- [...]
Checkpoint Therapeutics to Present at September 2019 Investor Conferences
04/09/2019
NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Aduro Biotech Announces First Patient Dosed in Phase 2 Study of ADU-S100 (MIW815) in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
04/09/2019
BERKELEY, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) [...]
Hepion Pharmaceuticals to Present at the H. C. Wainwright 21st Annual Global Investment Conference
04/09/2019
EDISON, N.J., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from [...]
Fluidigm Launches Imaging Mass Cytometry Immuno-Oncology Panel Kits and Advanced CyTOF Software at the 2019 World Molecular Imaging Congress (WMIC)
04/09/2019
Fluidigm Showcases Immuno-Oncology Imaging Innovations at WMIC to Advance Translational and Clinical Cancer Research SOUTH SAN FRANCISCO, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), [...]
GW Pharmaceuticals to Present at the Morgan Stanley 17th Annual Global Healthcare Conference on Wednesday, September 11th, 2019
04/09/2019
CARLSBAD, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, [...]
Demant A/S: Update on IT infrastructure incident
04/09/2019
Demant A/S: Update on IT infrastructure incident Company announcement no 2019-09 4 September 2019 As previously announced, the Demant Group has experienced a critical incident on our internal IT infrastructure on 3 [...]
Cognition Therapeutics to Give Webcast Presentation at 3rd Annual Janney Healthcare Conference on September 9, 2019
04/09/2019
Pittsburgh, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease and other [...]
Krystal Biotech Announces Initiation of Phase 1/2 Study of KB105 in Transglutaminase-1 (“TGM1”) Deficient Autosomal Recessive Congenital Ichthyosis (“ARCI”)
04/09/2019
PITTSBURGH, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company developing medicines to treat rare skin diseases, today announced the initiation of the Phase 1/2 [...]
Chembio Diagnostics Announces $20 Million Term Loan with Perceptive Advisors
04/09/2019
MEDFORD, N.Y., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the closing of a $20 million term [...]

Pages